Cita APA

Zhu, C., You, Y., Nie, K., & Ji, Y. (2019). Icotinib plus osimertinib overcome epidermal growth factor receptor 19del/T790 M/C797S/V834L quadruplet resistance mutation in a patient with non-small cell lung cancer. Chin Med J (Engl).

Chicago Style Citation

Zhu, Chao, Yun-Hong You, Ke-Ke Nie, i You-Xin Ji. "Icotinib Plus Osimertinib Overcome Epidermal Growth Factor Receptor 19del/T790 M/C797S/V834L Quadruplet Resistance Mutation in a Patient With Non-small Cell Lung Cancer." Chin Med J (Engl) 2019.

Cita MLA

Zhu, Chao, Yun-Hong You, Ke-Ke Nie, i You-Xin Ji. "Icotinib Plus Osimertinib Overcome Epidermal Growth Factor Receptor 19del/T790 M/C797S/V834L Quadruplet Resistance Mutation in a Patient With Non-small Cell Lung Cancer." Chin Med J (Engl) 2019.